SCHEMBL24936213

SCHEMBL24936213

CC(C)(C)c1cn(CC2CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PHF8 Q9UPP1 1/20 0.42
▸ KDM2B Q8NHM5 1/20 0.36
▸ WDR5 P61964 3/20 0.36
▸ KDM4C Q9H3R0 1/20 0.35
▸ USP30 Q70CQ3 1/20 0.34
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CPB2 Q96IY4 2/20 0.33
▸ CYP2B6 P20813 1/20 0.33
▸ CNR2 P34972 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ MAPK13 O15264 1/20 0.32
▸ MAPK12 P53778 1/20 0.32
▸ MAPK11 Q15759 1/20 0.32
▸ MAPK14 Q16539 1/20 0.32
▸ CYP11B2 P19099 1/20 0.31
▸ JAK2 O60674 1/20 0.31
▸ JAK1 P23458 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24936210 0.93 KDM4C (0.39) PHF8KDM2BWDR5KDM4CUSP30
SCHEMBL19859618 0.77 CHRNB2 (0.39) —
SCHEMBL19700911 0.75 PI4KA (0.33) —
SCHEMBL10064777 0.75 CYP2E1 (0.40) CPB2CYP2B6
SCHEMBL21724275 0.72 PHF8 (0.38) PHF8KDM4CCNR2JAK2JAK1
SCHEMBL12690266 0.72 FFAR1 (0.32) —
SCHEMBL10064778 0.72 KDM2B (0.43) PHF8KDM2B
SCHEMBL10064780 0.72 KDM5A (0.39) CPB2CPB1
SCHEMBL2378140 0.72 PHF8 (0.45) PHF8KDM2BWDR5KDM4CUSP30
SCHEMBL16972901 0.72 PHF8 (0.45) PHF8KDM2BWDR5KDM4CUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230022304-A1 WDR5-MYC INHIBITORS VANDERBILT UNIVERSITY 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230022304-A1 WDR5-MYC INHIBITORS MYC, WDR5, MYCBP PHF8 597/4885KDM2B 937/4885WDR5 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback